Key result
A patient with pulmonary tumor thrombotic microangiopathy following lymphedema developed pulmonary hypertension and died on the 9th day of admission, with autopsy revealing a tumor embolism.
Why the study?
Pulmonary tumor thrombotic microangiopathy is a rare manifestation of malignancy that presents with rapidly progressive symptoms, making antemortem diagnosis difficult.
Case Report (n=1)
This is the first reported case of pulmonary tumor thrombotic microangiopathy presenting with lymphedema of the lower extremities, highlighting the diagnostic difficulty and rapid progression of the disease.
PTTM may follow lower-extremity lymphedema with rapid fatality; this single case leaves open its value as an early marker and does not change practice.
Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare manifestation of malignancy. The antemortem diagnosis is difficult, since patients present with rapidly progressive symptoms. We recently observed a case of PTTM following lymphedema of the lower extremities. We did not reach a diagnosis, even after performing BAL and TBLB. The patient manifested pulmonary hypertension and died on the 9th day of admission. Autopsy revealed a tumor embolism in the pulmonary arterioles accompanied by fibrocellular epithelial cell proliferation, but the primary organ was not identified. To our knowledge, this is the first reported case of PTTM with lymphedema.
No takes yet. Share an insight, caveat, or question.
Shiraiwa et al. (2022) conducted a case report in Pulmonary tumor thrombotic microangiopathy (PTTM) (n=1). Pulmonary tumor thrombotic microangiopathy following lymphedema was evaluated on Clinical outcome and autopsy findings. A patient with pulmonary tumor thrombotic microangiopathy following lymphedema developed pulmonary hypertension and died on the 9th day of admission, with autopsy revealing a tumor embolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: